Generic Cycloset: An Overview
Cycloset™ (
bromocriptine mesylate) is a prescription medication approved to treat
type 2 diabetes. It belongs to a group of medications known as ergot alkaloids or dopamine agonists.
Brand-name Cycloset is manufactured by Patheon, Inc. for VeroScience LLC. This medication is protected by patents that prevent any generic versions from being sold in the United States.
When Will a Generic Form of Cycloset Be Available?
The first patent for Cycloset currently expires in November 2012. This is the earliest predictable date that a generic version of Cycloset could become available. However, there are other circumstances that could come up to extend or shorten the exclusivity period of Cycloset (this could include such things as lawsuits or other patents for specific
Cycloset uses). Once Cycloset goes off patent, there may be several companies that will manufacture a generic Cycloset drug.
Is Bromocriptine a Generic Cycloset?
The answer is no.
Bromocriptine is the active ingredient in Cycloset but is not a generic version of the drug. Confusingly, bromocriptine has been available as a generic medication for a very long time, but generic bromocriptine is not equivalent to Cycloset. Generic bromocriptine is equivalent to
Parlodel®, a medication that is available in different strengths and approved for different uses.
